Belle Mead, NJ, United States of America

Huiping Zhang


Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
6 patents (USPTO):

Title: The Innovations of Huiping Zhang: A Pioneer in Alzheimer’s Disease Research

Introduction

Huiping Zhang, located in Belle Mead, NJ, is an accomplished inventor with a notable portfolio of six patents. Her innovative work primarily focuses on pharmaceutical compounds and processes that have significant implications for treating Alzheimer’s disease and other related conditions. Zhang’s contributions to the field of medicinal chemistry showcase her dedication to advancing healthcare solutions.

Latest Patents

Among her most recent inventions is the patent for an alpha-(N-sulfonamido)acetamide compound, which acts as an inhibitor of beta amyloid peptide production. This novel compound provides a method for treating Alzheimer's disease and offers potential advancements in tackling conditions associated with beta-amyloid peptides. Additionally, she developed an efficient synthesis process for 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones, which can serve as factor Xa inhibitors. These compounds represent significant strides in drug development aimed at enhancing patient care.

Career Highlights

Zhang is affiliated with Bristol-Myers Squibb Company, an esteemed pharmaceutical company known for its commitment to discovering and developing innovative medicines. Her research plays a crucial role in the company's ongoing efforts to provide new therapies that can improve patients' lives.

Collaborations

Throughout her career, Huiping Zhang has collaborated with esteemed colleagues such as Bang-Chi Chen and Lucius Rossano. These partnerships underline the importance of teamwork in scientific research and highlight how collaborative efforts can lead to groundbreaking inventions that address critical health issues.

Conclusion

Huiping Zhang’s innovative spirit and dedication make her a significant figure in the field of medicinal chemistry. Her contributions through patents not only enhance our understanding of Alzheimer’s disease and its treatment but also exemplify the impact of research and collaboration within the pharmaceutical industry. As she continues her work at Bristol-Myers Squibb, her future innovations hold great promise for advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…